{
    "clinical_study": {
        "@rank": "43349", 
        "arm_group": {
            "arm_group_label": "OCFighter", 
            "arm_group_type": "Experimental", 
            "description": "OCFighter"
        }, 
        "brief_summary": {
            "textblock": "The primary aim of this study is to learn about who is most likely to benefit from guided\n      self-help (GSH) for obsessive-compulsive disorder (OCD)."
        }, 
        "brief_title": "Effectiveness and Neuropsychological Predictors of Guided Self-Help for Obsessive-Compulsive Disorder (OCD)", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Obsessive-Compulsive Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Obsessive-Compulsive Disorder", 
                "Compulsive Personality Disorder"
            ]
        }, 
        "detailed_description": {
            "textblock": "40 Participants with OCD will be recruited.  They will be given access to OC Fighter, an\n      internet OCD treatment program. During the 17 week program, participants will meet with a\n      therapist 9 times.  Assessments will occur at pretreatment, post-treatment, 3-month follow\n      up and 6-month follow up."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Principal or co-principal diagnosis of OCD\n\n          -  Clinical global impression score greater than or equal to 4\n\n          -  Y-BOCS score great than or equal to 16\n\n          -  Fluency in English\n\n          -  Capacity to understand the nature of the study and willingness to sign informed\n             consent form\n\n        Exclusion Criteria:\n\n          -  Active manic episode, psychosis, pervasive developmental disorder, mental retardation\n\n          -  Concurrent OCD psychotherapy\n\n          -  Current threat of harm to self or others\n\n          -  Previous adequate trial of therapist-administered or self-administered exposure and\n             response prevention for OCD"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "69 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01659125", 
            "org_study_id": "DIEF003581HI"
        }, 
        "intervention": {
            "arm_group_label": "OCFighter", 
            "description": "OCFighter\u2122 s an interactive, internet guided self-help (GSH) treatment program for obsessive-compulsive disorder (OCD). It uses the evidence based approach known as Cognitive Behavioral Therapy (CBT) and was adapted from the previously validated BT STEPS program for OCD.  The program teaches the best practice CBT technique to help with OCD called exposure with ritual prevention (ERP).", 
            "intervention_name": "\"OCFighter\"", 
            "intervention_type": "Behavioral", 
            "other_name": [
                "OCFighter", 
                "Guided Self-help"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 18, 2013", 
        "location": {
            "contact": {
                "email": "GDiefen@harthosp.org", 
                "last_name": "Gretchen Diefenbach, Ph.D.", 
                "phone": "860-545-7396"
            }, 
            "facility": {
                "address": {
                    "city": "Hartford", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06106"
                }, 
                "name": "Hartford Hospital"
            }, 
            "investigator": {
                "last_name": "Gretchen Diefenbach, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effectiveness and Neuropsychological Predictors of Guided Self-Help for OCD", 
        "overall_contact": {
            "email": "GDiefen@Harthosp.org", 
            "last_name": "Gretchen Diefenbach, Ph.D.", 
            "phone": "860-545-7396"
        }, 
        "overall_official": {
            "affiliation": "Hartford Hospital", 
            "last_name": "Gretchen Diefenbach, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The Y-BOCS is a semi-structured interview that assesses severity of obsessions and compulsions.", 
            "measure": "Change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)", 
            "safety_issue": "No", 
            "time_frame": "Change in Y-BOCS will be assessed over the course of the 17 week treatment trial, then again three months and six months after the treatment."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01659125"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Hartford Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hartford Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}